Showing results (111-120 of 195) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|May 28, 1994
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialR P Kedar, T H Bourne, T J Powles, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Serum markers for primary and recurrent breast cancer: BCM-EIA, CAM 26 and CAM 29D Ricketts, L Hadcocks, M Fitzek, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trialsM Trumper, P J Ross, D Cunningham, et al.
Radiology|February 1, 1996
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlationS J Vinnicombe, A D MacVicar, R L Guy, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancerM Dowsett, D Smithers, J Moore, et al.
Leukemia & Lymphoma|January 1, 1994
Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experienceM E O'Brien, E Matutes, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programmeT J Powles, C R Tillyer, A L Jones, et al.
Lancet (London, England)|February 9, 1980
Assessment of biochemical tests to screen for metastases in patients with breast cancerR C Coombes, T J Powles, J C Gazet, et al.
Pageof 20